CSF3R and hematopoietic and lymphoid cell neoplasm: For example, in hematological cancers SRSF2 mutations have been shown to increase levels of a normally minor CSF3R transcript encoding a truncated V684Afs*34 CSF3R isoform shown to inhibit differentiation [129].